KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

support building, page-3

  1. Tibbs
    12,454 Posts.
    lightbulb Created with Sketch. 265
    clock Created with Sketch.
    10/05/05
    19:16
    Post #: 902858
    re: support building - 70% controle rate!! Looks great

    Twenty (20) subjects received a combination of PXD + cisplatin and 20 patients received PXD + paclitaxel. Eighty (80) percent of subjects on combination therapy had either complete response (11%), partial response (22%), or stabilized disease (44%), providing an overall disease control rate of 77%. The PXD and cisplatin or paclitaxel combinations were well tolerated, with no unexpected toxicities encountered

    NRT Price at posting: 0.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
NEWS Microcap Wrap: 5 explorers with news out today
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.